Immersive virtual reality environments designed for exposure therapy, relaxation, and cognitive exercises.
Comprehensive tools for clinicians to monitor patient progress, adjust treatments, and access real-time data.
Interventions developed by mental health experts and backed by clinical research for various conditions.
Ability to tailor therapy modules to specific patient needs, conditions, and organizational requirements.
HIPAA-compliant platform with robust encryption and privacy measures to protect patient information.
Solutions designed for individual clinics, hospitals, or large organizations, with easy expansion options.
APIs and tools to integrate with existing electronic health records (EHR) and healthcare systems.
VR scenarios simulate social interactions to help teens practice and reduce anxiety in a controlled environment.
Employee wellness initiatives using VR for stress reduction, resilience training, and mental health support.
Exposure therapy modules for trauma survivors, administered in clinical settings with clinician oversight.
Support for students with anxiety or depression through engaging VR exercises integrated into school programs.
VR distraction techniques and mindfulness exercises to alleviate pain and improve quality of life.
Coping skills training and relapse prevention strategies using immersive simulations for substance use disorders.
Tailored modules for service-related mental health issues, such as combat stress and adjustment disorders.
Remote therapy sessions with VR components, enabling accessible care for patients in various locations.
Platform for studying the efficacy of digital therapeutics in controlled research environments.
Simulations for mental health first aid, empathy building, and resilience training in organizational settings.
Sign in to leave a review
Akili Interactive is a pioneering digital therapeutics company that develops and distributes FDA-cleared video game-based treatments for cognitive disorders, primarily focusing on conditions like attention deficit hyperactivity disorder (ADHD) in children. Their flagship product, EndeavorRx, is designed as a prescription digital therapeutic that targets specific neural networks through engaging gameplay to improve attention and focus. Founded on rigorous clinical research, Akili's platforms combine cutting-edge neuroscience with interactive technology to deliver personalized interventions. The company aims to provide safe, effective, and accessible alternatives to traditional pharmaceuticals, with applications in healthcare settings, telehealth, and home use. Akili Interactive is committed to advancing digital medicine by leveraging game mechanics to enhance cognitive functions, backed by regulatory approvals and ongoing studies for broader mental health applications.
Biofourmis is a pioneering digital health company that specializes in AI-driven remote patient monitoring and personalized care solutions. Their flagship platform, Biovitals, leverages advanced machine learning algorithms to analyze continuous physiological data collected from wearable sensors. This enables healthcare providers to monitor patients in real-time, detect early signs of health deteriorations, and intervene proactively. The platform is designed to manage a wide range of clinical conditions, including chronic heart failure, diabetes, hypertension, and post-operative recovery. By integrating seamlessly with electronic medical record systems, Biofourmis facilitates efficient data flow and enhances clinical decision-making. The company serves various stakeholders, from large hospital systems to pharmaceutical companies conducting decentralized clinical trials. Biofourmis aims to improve patient outcomes, reduce hospital readmissions, and lower healthcare costs through data-driven insights. Their technology is scalable, secure, and compliant with global healthcare regulations, making it a trusted partner in transforming care delivery. With a focus on innovation, Biofourmis continues to expand its capabilities, offering tools for predictive analytics, personalized treatment plans, and population health management.
Pear Therapeutics is a pioneering company in the field of prescription digital therapeutics (PDTs), developing software-based treatments that are prescribed by healthcare providers to manage and treat medical conditions. Their flagship products, such as reSET for substance use disorder and reSET-O for opioid use disorder, are FDA-cleared and delivered via mobile applications. These therapeutics leverage evidence-based techniques like cognitive behavioral therapy and contingency management to help patients modify behaviors, improve adherence, and achieve better health outcomes. By integrating digital tools into clinical care, Pear Therapeutics aims to enhance accessibility, support remote monitoring, and reduce healthcare costs. The company focuses on validating its interventions through clinical trials and real-world evidence, positioning itself at the forefront of digital health innovation. Their solutions are designed to complement traditional treatments, offering scalable and personalized options for mental health and addiction care, thereby addressing critical gaps in the healthcare system.
